Issues Surrounding Incentives and Penalties for COVID-19 Vaccination: The Israeli Experience

Overview

Journal Prev Med

Specialty Public Health

Date 2021 Aug 5

PMID 34352308

Citations 16

Authors

Mor Saban

Vicki Myers

Shani Ben Shetrit

Rachel Wilf-Miron

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to examine patterns of COVID-19 vaccination in Israel and how these relate to different proposals made about benefits for those vaccinated, and to present the legal and ethical dilemmas surrounding these issues. A retrospective study of COVID-19 vaccination rates in Israel was conducted, with data obtained from the Ministry of Health (MOH). Information on benefits proposed or offered for vaccination and restrictions for non-vaccination were obtained from the MOH and presented in a timeline. By March 1st, 51% of the total population, and 91% of those aged 60 and over, had received their first COVID-19 vaccine. Exemption from quarantine was granted to vaccinated or recovered people from 17th January 2021. The 'green pass' incentive scheme, granting access to social, cultural and sporting events for those fully vaccinated or immune, was proposed in December 2020, and came into effect on February 21st 2021. Incentive schemes which impose limitations on those who choose not to vaccinate may motivate some people to take action. Policymakers should use a measured approach to protect public health, with minimum infringement on citizens' rights. Providing transparent and culturally appropriate information on immunization and ensuring maximal and equitable access to COVID-19 vaccines may help build trust.

Citing Articles

Two centuries of vaccination: historical and conceptual approach and future perspectives.

Montero D, Vidal R, Velasco J, Carreno L, Torres J, Benachi O M Front Public Health. 2024; 11:1326154.

PMID: 38264254 PMC: 10803505. DOI: 10.3389/fpubh.2023.1326154.

Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping review.

Natalia Y, Delporte M, De Witte D, Beutels P, Dewatripont M, Molenberghs G BMC Public Health. 2023; 23(1):2279.

PMID: 37978472 PMC: 10656887. DOI: 10.1186/s12889-023-17203-4.

Association between COVID-19 vaccination and critical outcomes among older adults with dementia: a comparative cohort study.

Radomyslsky Z, Kivity S, Lidar S, Bentur N, Korn L, Nissanholtz-Gannot R Front Public Health. 2023; 11:1281266.

PMID: 37849724 PMC: 10578450. DOI: 10.3389/fpubh.2023.1281266.

The Impact of Meso-Level Factors on SARS-CoV-2 Vaccine Early Hesitancy in the United States.

Kaliba A, Andrews D Int J Environ Res Public Health. 2023; 20(13).

PMID: 37444159 PMC: 10341526. DOI: 10.3390/ijerph20136313.

Estimation of Total Cost Required in Controlling COVID-19 Outbreaks by Financial Incentives.

Kim S, Hwang Y, Lee C, Kwak S, Kim J Int J Environ Res Public Health. 2023; 20(2).

PMID: 36673975 PMC: 9859412. DOI: 10.3390/ijerph20021217.

References

Curry S, Grothaus L, McBride C . Reasons for quitting: intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav. 1998; 22(6):727-39. DOI: 10.1016/s0306-4603(97)00059-2. View

Latkin C, Dayton L, Yi G, Konstantopoulos A, Boodram B . Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021; 270:113684. PMC: 7834519. DOI: 10.1016/j.socscimed.2021.113684. View

Fournet N, Mollema L, Ruijs W, Harmsen I, Keck F, Durand J . Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews. BMC Public Health. 2018; 18(1):196. PMC: 5789742. DOI: 10.1186/s12889-018-5103-8. View

Yue M, Wang Y, Low C, Yoong J, Cook A . Optimal Design of Population-Level Financial Incentives of Influenza Vaccination for the Elderly. Value Health. 2020; 23(2):200-208. DOI: 10.1016/j.jval.2019.08.006. View

Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D . High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines (Basel). 2021; 9(1). PMC: 7826844. DOI: 10.3390/vaccines9010042. View

Murphy J, Vallieres F, Bentall R, Shevlin M, McBride O, Hartman T . Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021; 12(1):29. PMC: 7782692. DOI: 10.1038/s41467-020-20226-9. View

Leahey T, LaRose J, Lanoye A, Fava J, Wing R . Secondary data analysis from a randomized trial examining the effects of small financial incentives on intrinsic and extrinsic motivation for weight loss. Health Psychol Behav Med. 2019; 5(1):129-144. PMC: 6521883. DOI: 10.1080/21642850.2016.1276460. View

Muhsen K, Naaminh W, Lapidot Y, Goren S, Amir Y, Perlman S . A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021. Lancet Reg Health Eur. 2021; 7:100130. PMC: 8177966. DOI: 10.1016/j.lanepe.2021.100130. View

Achat H, McIntyre P, Burgess M . Health care incentives in immunisation. Aust N Z J Public Health. 1999; 23(3):285-8. DOI: 10.1111/j.1467-842x.1999.tb01257.x. View

10.

French J, Deshpande S, Evans W, Obregon R . Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy. Int J Environ Res Public Health. 2020; 17(16). PMC: 7459701. DOI: 10.3390/ijerph17165893. View

11.

Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R . COVID-19 vaccines: Frequently asked questions and updated answers. Infect Dis Now. 2021; 51(4):319-333. PMC: 7910656. DOI: 10.1016/j.idnow.2021.02.007. View

12.

Lytras T, Kopsachilis F, Mouratidou E, Papamichail D, Bonovas S . Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis. Hum Vaccin Immunother. 2015; 12(3):671-81. PMC: 4964628. DOI: 10.1080/21645515.2015.1106656. View

13.

Vergara R, Sarmiento P, Lagman J . Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health (Oxf). 2021; 43(2):e291-e292. PMC: 7928772. DOI: 10.1093/pubmed/fdaa282. View

14.

Rosen B, Waitzberg R, Israeli A . Israel's rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021; 10(1):6. PMC: 7835664. DOI: 10.1186/s13584-021-00440-6. View

15.

Evrony A, Caplan A . The overlooked dangers of anti-vaccination groups' social media presence. Hum Vaccin Immunother. 2017; 13(6):1-2. PMC: 5489284. DOI: 10.1080/21645515.2017.1283467. View

16.

Chantler T, Karafillakis E, Wilson J . Vaccination: Is There a Place for Penalties for Non-compliance?. Appl Health Econ Health Policy. 2019; 17(3):265-271. DOI: 10.1007/s40258-019-00460-z. View

17.

Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E . Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021; 397(10277):875-877. PMC: 7906709. DOI: 10.1016/S0140-6736(21)00448-7. View